Ipamorelin CJC-1295 No DAC Blend brings two research peptides together in a single preparation, and each has its own experimental literature.
Work published on Ipamorelin covers pituitary physiology, receptor biology, endocrine signalling, and growth hormone secretagogue pharmacology.
CJC-1295 turns up in research on the GH/IGF-1 axis and on signalling by growth hormone–releasing hormone. Endocrine physiology, molecular characterisation, and peptide pharmacology round out the recorded research areas. The blend is stocked by OriginSequence as a vial-format research material, and product documentation accompanies it where applicable.
